**REGISTERED COMPANY NUMBER: 06882020 (England and Wales) REGISTERED CHARITY NUMBER: 1133051** ## Report of the Trustees and Unaudited Financial Statements for the Year Ended 31 March 2024 ## for Beanibazar Cancer and General Hospital Abacus tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT Beanibazar Cancer and General Hospital Contents of the Financial Statements for the Year Ended 31 March 2024 ||Page| |---|---| |Report of the Trustees|1 to 2| |Independent Examiner's Report|3 to 4| |Statement of Financial Activities|5| |Balance Sheet|6 to 7| |Notes to the Financial Statements|8 to 13| |Detailed Statement of Financial Activities|14 to 15| Beanibazar Cancer and General Hospital ## Report of the Trustees for the Year Ended 31 March 2024 The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). ## **OBJECTIVES AND ACTIVITIES Objectives and aims** The Charity's objects ('the Objects') are: (1) To provide for the erection and maintenance of a fully resourced hospital in the area of Beani Bazar, Sylhet, Bangladesh for the purposes of diagnosis, prevention and cure of all forms of cancer. (2) To provide information and raise public awareness of all such matters relating to cancer and healthcare. (3) To protect and promote the health of the public in the UK and Bangladesh with particular regard to the disadvantaged people originating from and residing in Beani Bazar, Sylhet, Bangladesh and surrounding areas. (4) To provide relief, support and assistance for people who suffer from or have suffered from any form of cancer and related illness. (5) To further all other charitable pursuits as deemed appropriate by the trustees with particular regard to cancer care and treatment which includes starting outdoor campaign, chemotherapy treatment, medical camps etc. ## **FINANCIAL REVIEW** Total incoming resources in the year amounted to £298,596 (2023: £225,315) with a net deficit of £8,817(2023: £18,817 deficit ) at the year end. ## **FUTURE PLANS** (1) The charity is working hard to expand on its services at the hospital in Bangladesh by recruiting additional specialist doctors and starting the mobile clinic service. The mobile clinic service will be a mobile vehicle with medical equipment visiting local areas and providing cancer prevention advice and general medical services to those in need. (2) We are also planning to expand the outreach work through medical camps and community health workers. (3) The Trustees are planning to raise funds through further marketing and fundraising events to fund our activities. (4) The charity plans to open a new centre for the hospital in Sylhet. This will enable further specialist treatments and medical services for the wider public. The hospital will also have access to a wider network of medical consultants and doctors. Page 1 Beanibazar Cancer and General Hospital ## Report of the Trustees ## for the Year Ended 31 March 2024 ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. ## **Risk management** The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. ## **REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number** 06882020 (England and Wales) ## **Registered Charity number** 1133051 ## **Registered office** 74-76 Tower Bridge Road London SE1 4TP ## **Trustees** Shamsuddin Khan - Chairman M Shab Uddin - CEO Shalim Uddin - Finance Director Mohammed N Uddin ## **Independent Examiner** Monzur Sumon MA, FCCA, ACA, CTA Abacus tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT Approved by order of the board of trustees on 13 December 2024 and signed on its behalf by: M Shab Uddin - Trustee Page 2 Independent Examiner's Report to the Trustees of Beanibazar Cancer and General Hospital ## **Independent examiner's report to the trustees of Beanibazar Cancer and General Hospital ('the Company')** I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2024. ## **Responsibilities and basis of report** As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act. Page 3 Independent Examiner's Report to the Trustees of Beanibazar Cancer and General Hospital ## **Independent examiner's statement** Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)). I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Monzur Sumon MA, FCCA, ACA, CTA Abacus tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT 13 December 2024 Page 4 Beanibazar Cancer and General Hospital ## Statement of Financial Activities for the Year Ended 31 March 2024 |Notes
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
Investment income
2
**Total**
**EXPENDITURE ON**
Raising funds
**Charitable activities**
HOSPITAL
**Total**
**NET INCOME/(EXPENDITURE)**
**RECONCILIATION OF FUNDS**
Total funds brought forward
**TOTAL FUNDS CARRIED FORWARD**|31.3.24
31.3.23
Unrestricted
Total
fund
funds
£
£
273,103
199,338
25,493
25,977
298,596
225,315
21,113
26,869
286,300
217,263
307,413
244,132
(8,817)
(18,817)
1,305,894
1,324,711
1,297,077
1,305,894| |---|---| The notes form part of these financial statements Page 5 Beanibazar Cancer and General Hospital ## Balance Sheet ## 31 March 2024 |Notes
**FIXED ASSETS**
Tangible assets
6
**CURRENT ASSETS**
Debtors
7
Cash at bank and in hand
**CREDITORS**
Amounts falling due within one year
8
**NET CURRENT ASSETS**
**TOTAL ASSETS LESS CURRENT**
**LIABILITIES**
**NET ASSETS**
**FUNDS**
9
Unrestricted funds
**TOTAL FUNDS**|31.3.24
31.3.23
Unrestricted
Total
fund
funds
£
£
555,943
533,684
1,238
-
745,136
779,818
746,374
779,818
(5,240)
(7,608)
741,134
772,210
1,297,077
1,305,894
1,297,077
1,305,894
1,297,077
1,305,894
1,297,077
1,305,894| |---|---| The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024. The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006. - The trustees acknowledge their responsibilities for - (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and - (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. The notes form part of these financial statements Page 6 continued... Beanibazar Cancer and General Hospital Balance Sheet - continued 31 March 2024 These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. The financial statements were approved by the Board of Trustees and authorised for issue on 13 December 2024 and were signed on its behalf by: M Shab Uddin - Trustee The notes form part of these financial statements Page 7 Beanibazar Cancer and General Hospital Notes to the Financial Statements for the Year Ended 31 March 2024 ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. ## **Tangible fixed assets** Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. |Plant and machinery|- 20% on reducing balance| |---|---| |Fixtures and fittings|- 20% on reducing balance| |Motor vehicles|- 20% on reducing balance| ## **Taxation** The charity is exempt from corporation tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. Page 8 continued... Beanibazar Cancer and General Hospital ## Notes to the Financial Statements - continued for the Year Ended 31 March 2024 ## **2. INVESTMENT INCOME** |Interest receivable
**3.**
**NET INCOME/(EXPENDITURE)**
Net income/(expenditure) is stated after charging/(crediting):
Depreciation - owned assets|31.3.24
£
25,493
31.3.24
£
15,510|31.3.23
£
25,977| |---|---|---| |||31.3.23
£
9,945| ## **4. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 31 March 2024 nor for the year ended 31 March 2023. ## **Trustees' expenses** There were no trustees' expenses paid for the year ended 31 March 2024 nor for the year ended 31 March 2023. ## **5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** |**INCOME AND ENDOWMENTS FROM**
Donations and legacies
Investment income
**Total**
**EXPENDITURE ON**
Raising funds
**Charitable activities**
HOSPITAL
**Total**
**NET INCOME/(EXPENDITURE)**
**RECONCILIATION OF FUNDS**
Total funds brought forward|Unrestricted
fund
£
199,338
25,977
225,315
26,869
217,263
244,132
(18,817)
1,324,711| |---|---| Page 9 continued... Beanibazar Cancer and General Hospital Notes to the Financial Statements - continued for the Year Ended 31 March 2024 ## **5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued** |**TOTAL FUNDS CARRIED**
**FORWARD**
**6.**
**TANGIBLE FIXED ASSETS**
**COST**
At 1 April 2023
Additions
At 31 March 2024
**DEPRECIATION**
At 1 April 2023
Charge for year
At 31 March 2024
**NET BOOK VALUE**
At 31 March 2024
At 31 March 2023
**COST**
At 1 April 2023
Additions
At 31 March 2024
**DEPRECIATION**
At 1 April 2023
Charge for year
At 31 March 2024
**NET BOOK VALUE**
At 31 March 2024
At 31 March 2023|Freehold
property
£
493,900
-
493,900
-
-
-
493,900
493,900
Motor
vehicles
£
14,400
23,287
37,687
11,342
5,269
16,611
21,076
3,058|Plant and
machinery
£
162,084
14,482
176,566
131,981
8,917
140,898
35,668
30,103
Computer
equipment
£
714
-
714
348
73
421
293
366||Unrestricted
fund
£
1,305,894
Fixtures
and
fittings
£
30,361
-
30,361
24,104
1,251
25,355
5,006
6,257
Totals
£
701,459
37,769
739,228
167,775
15,510
183,285
555,943
533,684| |---|---|---|---|---| |||||| |||||| Page 10 continued... Beanibazar Cancer and General Hospital ## Notes to the Financial Statements - continued for the Year Ended 31 March 2024 |**7.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Trade debtors
**8.**
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Trade creditors
Social security and other taxes
Other creditors
**9.**
**MOVEMENT IN FUNDS**
At 1.4.23
£
**Unrestricted funds**
General fund
1,305,894
**TOTAL FUNDS**
1,305,894
Net movement in funds, included in the above are as follows:
Incoming
resources
£
**Unrestricted funds**
General fund
298,596
**TOTAL FUNDS**
298,596
**Comparatives for movement in funds**
At 1.4.22
£
**Unrestricted funds**
General fund
1,324,711
**TOTAL FUNDS**
1,324,711||31.3.24
31.3.23
£
£
1,238
-
31.3.24
31.3.23
£
£
-
1,740
1,435
1,908
3,805
3,960
5,240
7,608
Net
movement
At
in funds
31.3.24
£
£
(8,817)
1,297,077
(8,817)
1,297,077
Resources
Movement
expended
in funds
£
£
(307,413)
(8,817)
(307,413)
(8,817)
Net
movement
At
in funds
31.3.23
£
£
(18,817)
1,305,894
(18,817)
1,305,894| |---|---|---| |||| |||| |||| Page 11 continued... Beanibazar Cancer and General Hospital Notes to the Financial Statements - continued for the Year Ended 31 March 2024 ## **9. MOVEMENT IN FUNDS - continued** Comparative net movement in funds, included in the above are as follows: ||Incoming|Resources|Movement|Movement| |---|---|---|---|---| ||resources|expended||in funds| ||£|£||£| |**Unrestricted funds**||||| |General fund|225,315|(244,132)||(18,817)| |**TOTAL FUNDS**|225,315|(244,132)||(18,817)| |A current year 12 months and prior year 12 months combined position is as follows:||||| |||Net||| |||movement||At| ||At 1.4.22|in funds||31.3.24| ||£|£||£| |**Unrestricted funds**||||| |General fund|1,324,711|(27,634)|1,297,077|| |**TOTAL FUNDS**|1,324,711|(27,634)|1,297,077|| |A current year 12 months and prior year|12 months combined|net movement||in fund| |included in the above are as follows:||||| ||Incoming|Resources|Movement|| ||resources|expended||in funds| ||£|£||£| |**Unrestricted funds**||||| |General fund|523,911|(551,545)||(27,634)| |**TOTAL FUNDS**|523,911|(551,545)||(27,634)| A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: Page 12 continued... Beanibazar Cancer and General Hospital Notes to the Financial Statements - continued for the Year Ended 31 March 2024 ## **10. RELATED PARTY DISCLOSURES** There were no related party transactions for the year ended 31 March 2024. Page 13 |Beanibazar Cancer and General Hospital
Detailed Statement of Financial Activities
for the Year Ended 31 March 2024
**INCOME AND ENDOWMENTS**
**Donations and legacies**
Donations
**Investment income**
Interest receivable
**Total incoming resources**
**EXPENDITURE**
**Other trading activities**
Purchases
**Charitable activities**
Wages
Insurance
Telephone
Sundries
Donation
Room Hire
Rent
Light and Heat
Repairs and maintenance
Stationery and Printing
Household and Cleaning
Travel and Subsistence
Motor Vehicle Expenses
Subscriptions
Software
Food & Refreshment
Equipment Hire
Advertising
Equipment expensed
Exchange gain/loss
Temp & Recruitment
Other Legal and Professional
**Support costs**
**Management**
Social security|31.3.24
£
273,103
25,493
298,596
21,113
75,605
480
2,106
236
4,256
-
6,879
4,172
3,873
1,091
1,120
7,110
4,701
3,647
4,268
1,407
2,145
25,886
578
74,134
8,622
29,947
262,263
-|31.3.23
£
199,338
25,977| |---|---|---| |||225,315
26,869
66,844
547
1,897
1,138
-
14,460
6,834
3,026
5,083
974
1,059
2,360
8,863
2,448
2,549
1,825
3,119
16,324
3,559
28,902
5,883
23,425| |||201,119
1,132| This page does not form part of the statutory financial statements Page 14 Beanibazar Cancer and General Hospital Detailed Statement of Financial Activities for the Year Ended 31 March 2024 |**Management**
**Finance**
Depreciation of tangible fixed assets
**Governance costs**
Accountancy and legal fees
Bank Charges
Total resources expended
**Net expenditure**|31.3.24
£
15,510
2,750
5,777
8,527
307,413
(8,817)|31.3.23
£
9,946
3,000
2,066
5,066
244,132
(18,817)| |---|---|---| This page does not form part of the statutory financial statements Page 15